Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Under recommendations released Tuesday night, obesity would no longer be defined solely by BMI, a calculation of height and ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...

Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...

New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular ...

U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...